Catalent CEO Alessandro Maselli at #JPM24 (Brian Benton Photography)
January 10, 2024 12:04 PM ESTUpdated 12:34 PM
Manufacturing

Catal­ent touts GLP-1 man­u­fac­tur­ing; Telix grows ra­dio­phar­ma ca­pac­i­ty; Arc­turus ex­pands in Japan: #JPM24

Anna Brown

News Reporter

Catal­ent’s stock $CTLT rose to the high­est it’s been in three months on Tues­day af­ter CEO Alessan­dro Masel­li em­pha­sized the CD­MO’s big pic­ture plan to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times